CLOVER BIO-B

2197
1.6550.60% ( -0.010 )
Delay Closed: Nov 16, 16:08:11

Financials

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: CLOVER BIO-B(02197) the Revenue is 103.38 K (-94.2%);the EBIT is -90.52 M (-44.76%);the EPS is 0.427 (+1070%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B94.20%
----
----
EBIT
-0.09B44.76%
----
----
EPS
0.42741069.72%
----
----

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateNov 25, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly